Solid Dosage
Cardiovascular medication
GEA provides proven solutions for manufacturing even the most challenging dosage forms of cardiovascular medication.
Manufacturing Cardiovascular Medication
There are many types and combinations of medicines available to treat coronary heart disease (CHD), high blood pressure or heart failure, including anticoagulants, antiplatelet medications, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta blockers, calcium channel blockers, digoxin and diuretics.
Whatever the active ingredient, GEA provides proven solutions for even the most challenging dosage forms, such as MUPS tablets, effervescents and multi-layer dosage forms, as well as granules, pellets, modified/extended release formulations, powders designed for direct tableting or capsule filling and high-volume applications.
Still an important unit operation, coating is used to either add color, protect, mask the taste or create a modified release form in pharmaceutical production. GEA offers a range of standard, innovative, batch and continuous coater systems
Plus, as containment experts, the company offers the largest selection of solutions for contained processing based on a thorough containment risk analysis.
Providing increased yields, lower utility consumption and reduced waste, continuous manufacturing presents a new approach to high-volume oral dosage form production and meets the industry’s demands for faster product development, reduced costs, improved production economics and increased manufacturing flexibility.
المنتجات والتقنيات
يتم عرض 4 من 26
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Continuous Processing Lines for Pharma
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Downloads
رؤى GEA
تغذية المستقبل: قوة الابتكار في التجفيف بالتجميد
يعد تقليل النفايات أمرًا مهمًا بالنسبة لنا في GEA، ومن خلال الاستفادة من قوة تكنولوجيا التجفيف بالتجميد، يمكننا تحويل فائض الطعام إلى منتجات قيِّمة وطويلة الأمد - مما يساعد على تقليل النفايات وإطالة العمر الافتراضي للمنتجات وبناء إمدادات غذائية أكثر مرونة للأجيال القادمة.
GEA وPulmuone تكرّمان أجيالاً من حرفي صنع النودلز الباردة
كان خبراء البحث والتطوير في GEA على قدر التحدي عندما طرحت Pulmuone، وهي شركة كورية جنوبية متخصصة في إنتاج الأغذية النباتية، تحديًا لـ GEA يتمثل في إضفاء لمسة حديثة على النودلز الكورية الباردة التقليدية ذات القوام الواضح في الفم (النينجميون). وساعدوا في تطوير ما أصبح الآن نجاحًا تجاريًا يتم إنتاجه باستخدام كميات أقل من المياه والكهرباء مقارنةً بالطرق المستخدمة سابقًا. وتتوافق النتيجة أيضًا مع الأصول التقليدية للطبق بالإضافة إلى جذور Pulmuone في الصحة والعافية والاستدامة.
